Native T1-mapping as a predictor of progressive renal function decline in chronic kidney disease patients

To investigate the potential of Native T1-mapping in predicting the prognosis of patients with chronic kidney disease (CKD). We enrolled 119 CKD patients as the study subjects and included 20 healthy volunteers as the control group, with follow-up extending until October 2022. Out of these patients, 63 underwent kidney biopsy measurements, and these patients were categorized into high (25–50